Moleculin Biotech Stock Momentum Indicators 1 day Rate Of Change of a Triple Smooth EMA
| MBRX Stock | USD 2.62 0.03 1.13% |
| Symbol |
null. The output start index for this execution was zero with a total number of output elements of zero. The 1-day Rate-Of-Change (ROC) of a Triple Smooth EMA is an alternative momentum indicator that shows Moleculin Biotech trend by ignoring insignificant cycles.
Moleculin Biotech Technical Analysis Modules
Most technical analysis of Moleculin Biotech help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Moleculin from various momentum indicators to cycle indicators. When you analyze Moleculin charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Moleculin Biotech Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Moleculin Biotech. We use our internally-developed statistical techniques to arrive at the intrinsic value of Moleculin Biotech based on widely used predictive technical indicators. In general, we focus on analyzing Moleculin Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Moleculin Biotech's daily price indicators and compare them against related drivers, such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Moleculin Biotech's intrinsic value. In addition to deriving basic predictive indicators for Moleculin Biotech, we also check how macroeconomic factors affect Moleculin Biotech price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2021 | 2022 | 2024 (projected) | Net Debt To EBITDA | 3.1 | 1.4 | 0.94 | Intangibles To Total Assets | 0.13 | 0.19 | 0.45 |
Be your own money manager
As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.Generate Optimal Portfolios
Align your risk and return expectations
Additional Tools for Moleculin Stock Analysis
When running Moleculin Biotech's price analysis, check to measure Moleculin Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Moleculin Biotech is operating at the current time. Most of Moleculin Biotech's value examination focuses on studying past and present price action to predict the probability of Moleculin Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Moleculin Biotech's price. Additionally, you may evaluate how the addition of Moleculin Biotech to your portfolios can decrease your overall portfolio volatility.